{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00642840200",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p16161"
      },
      "name": "Population pharmacokinetics in support of analgesics and anaesthetics studies in special populations"
    },
    {
      "@id": "http://www.yso.fi/onto/yso/p16161",
      "name": "deksmedetomidiini"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00602974900",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p16161"
      },
      "name": "α₂-adrenoceptor-mediated vascular responses induced by dexmedetomidine"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00600092900",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p16161"
      },
      "name": "Dexmedetomidine and MK-467, a peripherally acting α2-adrenoceptor antagonist, in dogs"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00600720400",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p16161"
      },
      "name": "Observations on the pharmacokinetics and pharmacodynamics of dexmedetomidine : clinical studies on healthy volunteers and intensive care patients"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00303686200",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p16161"
      },
      "name": "Human pharmacology of medetomidine, a selective alpha[sub 2]-adrenoceptor agonist"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00911998000",
      "about": {
        "@id": "http://www.yso.fi/onto/yso/p16161"
      },
      "name": "Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs"
    }
  ]
}